In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. (Q53702693)

18 May 2018

title

In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. (English)

1 reference

18 May 2018

0 references

0 references

6

1 reference

18 May 2018

author name string

Emilie D

1

1 reference

18 May 2018

Touitou R

2

1 reference

18 May 2018

Raphael M

3

1 reference

18 May 2018

Peuchmaur M

4

1 reference

18 May 2018

Devergnee O

5

1 reference

18 May 2018

Coumbraras J

7

1 reference

18 May 2018

Crevon MC

8

1 reference

18 May 2018

Edelman L

9

1 reference

18 May 2018

Joab I

10

1 reference

18 May 2018

language of work or name

English

0 references

publication date

1 November 1992

1 reference

18 May 2018

number of pages

6

1 reference

European Journal of Immunology

inferred from page(s)

published in

1 reference

18 May 2018

volume

22

1 reference

18 May 2018

page(s)

2937-2942

1 reference

18 May 2018

issue

11

1 reference

18 May 2018

Detection of Anti-Epstein-Barr Virus trans-Activator (ZEBRA) Antibodies in Sera from Patients with Human Immunodeficiency Virus

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

Interleukin 10: a novel stimulatory factor for mast cells and their progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

The short unique region of the B95-8 Epstein-Barr virus genome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Human immunodeficiency virus induction of malignant transformation in human B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell l

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Cellular uptake of the tat protein from human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Stable expression of the tax gene of type I human T-cell leukemia virus in human T cells activates specific cellular genes involved in growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221127

7 January 2021

Identifiers

DOI

10.1002/EJI.1830221127

1 reference

18 May 2018

PubMed ID

1330578

1 reference

18 May 2018